Linjia Haoyi Completes Nearly RMB 100 Million New Round of Financing to Accelerate Family Healthcare Services

VCBeat (WeChat ID: vcbeat) has learned that Linjia Haoyi recently completed a new round of financing amounting to nearly RMB 100 million, with Tengyun Life Sciences Capital as the investor. Exactly one year has passed since the company’s last publicly announced funding round. Unlike previous rounds, this financing was exclusively provided by strategic industrial capital. Following the completion of this investment, both parties will engage in comprehensive cooperation across multiple urban scenarios focused on home healthcare services, jointly building healthy living circles within urban communities.

In 2021, Linjia Haoyi bucked the trend and achieved new operational successes. Meanwhile, it continued to promote value exploration based on family medical and health services, launching patient-centered, specialty-specific full-course disease management services. The digitalization of its business and products accelerated, and beneficial attempts were made in innovative payment models. To enrich the industrial ecosystem and establish service barriers, the company newly established “Ruolin Yishi,” forming a team of physician agents to provide the industry with short-video brand operation and traffic conversion services that combine public and private domain strategies. In the same year, the company also obtained an online pharmaceutical retail license, enabling “Linjia Haoyao” to extend pharmaceutical and health service capabilities into various scenarios of users’ lifestyles, thereby further improving the service offerings of Linjia Haoyi.

In the future, Linjia Haoyi will continue to serve as a new-type operator of urban family healthcare services within the industrial ecosystem, fully advancing the construction of industry-wide information infrastructure, the expansion of innovative healthcare services, the development of comprehensive patient management tools for physicians, and the enhancement of public health education outreach. The newly formed business matrix, comprising Linjia Haoyi, Linjia Haoyao, and Ruolin Yishi, will further drive the realization of the corporate mission: “Making Quality Healthcare Accessible.”

Mr. Wang Ge, CEO of Tengyun Big Health and Managing Partner of Tengyun Life Sciences Capital ManagementHe stated, “General practice is a crucial cornerstone for Tengyun Health in building an integrated service platform for community medical care, nursing, and health preservation, as well as in achieving its strategic positioning as a ‘community health service operator.’ We have long focused on entrepreneurial teams in the field of community general practice. Since 2020, the Linjia Haoyi team has withstood tests from the market, the pandemic, and various other uncertainties, initially establishing and validating a community medical service model characterized by ‘general practice leading specialty care’ and ‘online empowerment of offline services,’ while also achieving rapid cross-regional business growth. We believe that, leveraging their scarce digital DNA, innovative spirit, and strong execution capabilities within the community healthcare sector, the Linjia team will have the opportunity to synergize with the various industrial and disciplinary platforms laid out by Tengyun Health. Together, we strive to create an innovative community-based general practice medical service model suited to China’s local context, against the backdrop of tiered diagnosis and treatment.”

Tengyun Grand Health is an investment and operational platform enterprise for the grand health industry under the Century Golden Resources Group. Committed to coordinating the layout of the grand health industry system, integrating the industrial chain to build an innovative industrial ecosystem, and creating the Tengyun Grand Health (TWing One Health) industrial brand. With the corporate mission of achieving One Health and helping millions of community families achieve a healthy and happy life, it aims to become China's leading community health management service operator and a leading "Clinical + Technology" innovation incubation platform. It focuses on five major areas: health management, consumer healthcare, innovative medical devices, smart elderly care, and industrial investment, while building three supporting platforms: "Investment, Discipline, and Public Welfare." It is an important part of the Century Golden Resources Group's strategy to lead new business growth in its next thirty years, layout the four main channels of "Grand Consumption, Grand Culture and Tourism, Grand Health, and New Technology," and build a happiness industry ecosystem.

Tengyun Life Sciences Capital is the healthcare industry fund brand established by Tengyun Great Health to complete its industrial layout and achieve its development goals. Its portfolio includes fund-of-funds, strategic investment, and angel investment operations, positioning it as an evergreen capital firm in the healthcare and life sciences sectors driven by insight and innovation. The fund’s long-term mission is to lead innovation and foster a superior healthcare industry ecosystem, with the development goal of becoming a premier equity asset management company in the healthcare sector. In collaboration with Tengyun Fund of Funds, Tengyun Life Sciences Capital has invested in more than ten professional healthcare investment institutions, including Huaxing Healthcare Industry Fund, Guoke Jiahe, Fortune Capital (Dachen Capital), Chende Capital, Anlong Fund, Yahui Capital, and Yuanyi Capital, and has backed dozens of innovative startups in the healthcare and life sciences fields.